BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...

Cancer Focused Clovis Oncology Files For Bankruptcy

Clovis Oncology Inc (NASDAQ: CLVS) has voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process. The Debtors...

Clovis Oncology stock slides 10% premarket after company files for bankruptcy

Clovis Oncology Inc. stock CLVS, +19.83% fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell assets. The company has a commitment for up to $75...

GILD Stock Surges: Why Gilead Sees Its Oncology Business As A Force To Be Reckoned With

Gilead Sciences‘ (GILD) first-in-class cancer drug and GILD stock are finally hitting their stride. X The biotech company is an expert in a means of battling cancer by reprogramming a patient...

Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023

Clovis Oncology Inc. shares CLVS, -71.62% plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain operations beyond January of 2023. The company ...

Imara Agrees To Merge With Precision Oncology Player, Shares Surge

Motley Fool 3 Growth Stocks With More Potential Than Any Cryptocurrency Intuitive Surgical (NASDAQ: ISRG) leads the way in the vast, multi-billion-dollar surgical robotics industry, commanding an appr...

2 New Oncology Focused Small-Cap Biotechs to Keep an Eye On

The biotech sector has held up better than one would expect during the carnage and volatility in the markets over the past couple of months. The lows this sector made in mid-June have formed a firm fl...

Gilead stock price ‘does not’ reflect its oncology business: Analyst

Gilead Sciences Inc (NASDAQ: GILD) ended in the green on Tuesday after a JPMorgan analyst turned bullish on the biopharmaceutical company. Gilead stock should be worth $80 a share Chriss Schott now ra...

Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK

Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share in cash. That represents a total equity value of $1...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GSK

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy compa...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKline

Text size AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy company Sierra Oncology for $1.9 billion in cash, as it looks to boost its portfolio of new specialty medicine...

Oncology Pharma stock (ONPH) is up 24% over the past month: here is where to buy it

Oncology Pharma stock (ONPH) has been on the rise for the past month and today it is up by over 15%. The recent bullish trend has attracted lots of investors especially as some tech stocks like Meta d...

Hockey Fan Spots Cancerous Mole On Staff Member’s Neck At Game

Brian Hamilton (R) went to have a cancerous mole removed after Nadia Popovici (L) spotted it on him … [+] through the glass while watching her hockey team play. Vancouver Canucks Image Library A...